Gentex Corporation has acquired BioConnect, strengthening its position in biometric authentication and security solutions.
Information on the Target
BioConnect, headquartered in Toronto, is a prominent provider of biometric authentication solutions, specializing in a comprehensive multi-modal authentication software platform for security and access control. Established in 2010, the company originated from a desire among IT professionals to deliver enhanced identity verification solutions tailored for various industries.
The company has built a robust portfolio, serving over 1,500 clients across critical sectors such as data storage, healthcare, financial services, education, and manufacturing. BioConnect stands out for its ability to develop holistic security systems, particularly for IT data centers, where eight of the top ten U.S.-based data centers utilize its services to safeguard access to sensitive operations.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Canada
The biometric authentication industry in Canada has experienced significant growth, driven by increasing concerns over security and the need for advanced technology solutions across numerous sectors. Companies are increa
Similar Deals
Pomeroy Technologies, LLC → Soroc Technology
2024
Gentex Corporation
invested in
BioConnect
in 2025
in a Other deal